ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced updated efficacy and safety ...
Friday, ImmunityBio said the two complete responses are ongoing after seven and 15 months. The patients received four cycles ...
CAR T cells have made headlines for their ability to fight hematological cancers, but they have proven largely ineffective ...
Verywell Health on MSN
What Regular Exercise Can Do for Your Immune Health
Regular exercise supports immune health by improving the circulation of your immune cells and reducing inflammation, but overtraining may weaken defenses.
GTB-5550 represents GT Biopharma's third NK cell engager advancing toward clinical development, targeting B7-H3, a protein ...
Despite 700% net product revenue growth to $113 million, ImmunityBio's high debt load and unprofitability remain significant ...
A group of researchers in Japan says it has confirmed a certain level of efficacy in using iPS cell-derived immune cells for ...
ImmunityBio stock jumps after strong trial updates in bladder cancer and lymphoma, with enrollment ahead of schedule and FDA ...
It lowers levels of the stress hormone cortisol – a single session may reduce levels by 37 percent, according to UCLA Health ...
Shares surged 30% Thursday after reporting 700% Anktiva revenue growth and securing Saudi FDA approvals for lung and bladder ...
ImmunityBio’s Anktiva receives Saudi FDA approval for non-muscle invasive bladder cancer with carcinoma in-situ: Culver City, California Friday, January 16, 2026, 15:00 Hrs [IST ...
Biliary atresia (BA) is a life-threatening liver disease of infancy in which early surgery can restore bile flow but rarely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback